Clinical Trial Update: Effect of Metformin on Biomarkers of Colorectal Tumor Cell Growth [Phase 2]

View source ↗

Summary

A Phase 2 trial assessed whether metformin modulates biomarkers of colorectal tumor cell growth in colorectal cancer. The study was terminated, and results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University of Arkansas | Conditions: Colorectal Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2016-07-11